Search Results 701-710 of 16027 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
"We now understand that disease likely develops from gene variants that have modest effects on gene expression, and which are also found in healthy people. But ...
The purpose of this study is to identify risk factors and potential predictors for NAFLD and NASH recurrence after liver transplantation. Participation ...
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
Endocrine surgeons at Mayo Clinic offer unilateral adrenalectomy to reduce medication use for people with primary aldosteronism due to bilateral adrenal disease ...
The purpose of this study is to determine safety of plasma infusion in APOE 44 patients. Participation eligibility. Participant eligibility includes age, gender ...
The purpose of this study is to collect skin biopsies from patients who have known cases of chemotherapy induced peripheral neuropathy and analyze the samples ...
Hassan S, Anouti A, Tan QKG, Wangensteen K, Aqul A. Liver transplantation for pediatric genetic and metabolic disorders. Liver Transpl.
The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.